This bill amends an existing law (RCW 18.84.020) to add and clarify definitions related to radiologic technology and to create a new form of supervision called "virtual direct supervision." It explicitly allows diagnostic radiologic technologists, therapeutic radiologic technologists, and magnetic resonance imaging technologists to perform intravenous contrast procedures under virtual direct supervision rather than requiring the supervising physician to be physically present. The change is a procedural supervision change rather than a criminal or penalty change. Under the new definition, virtual direct supervision requires the supervising physician to be immediately available by real-time audio and visual interactive telecommunications and to be located within 30 miles of the facility where the procedure occurs. Virtual direct supervision must comply with all applicable federal and state laws and local or institutional telemedicine policies. Clinical staff with the training and qualifications to administer medications for adverse events must be present on-site during such supervision. The amendment also defines several education and practitioner terms (approved schools and programs, types of radiologic technologists, radiologist assistant, cardiovascular invasive specialist, registered X-ray technician, secretary, department, and radiologist) and references physicians licensed under chapters 18.71 and 18.57 RCW. Affected parties include the Department of Health, the Secretary of Health, multiple categories of technologists, radiologist assistants, cardiovascular invasive specialists, registered X-ray technicians, approved schools and affiliated hospitals, and supervising physicians. The provided text appears to be only the amended section 1 of the bill; it does not include other sections, effective dates, enforcement details, or specific standards for what constitutes the "requisite training and qualifications" for on-site clinical staff. The text also does not specify how the 30-mile distance is measured or provide further implementation procedures.

If enacted, diagnostic, therapeutic, and MRI technologists would be allowed to give intravenous contrast under a new “virtual direct supervision” model where the supervising physician does not need to be in the room but must be immediately available by real‑time audio/video and be located within 30 miles of the facility. Hospitals, clinics, and supervising physicians will need to adopt or follow telemedicine policies, keep a physician on remote standby within that distance, and ensure qualified clinical staff are on site who can give medications and respond to adverse events during these procedures. The practical changes likely increase options for scheduling and using technologists without a physician physically present, but will also create new costs and responsibilities: facilities must equip reliable audio/video connections and maintain trained on‑site staff, physicians must be available remotely and manage oversight from nearby, and the Department of Health and approved training programs may have expanded oversight duties. Key details are left unclear here—what specific training counts as “requisite,” how the 30‑mile distance is measured, and enforcement or timing of the change—so facilities and providers will face uncertainty until those are defined.